Navigation Links
Ellman International Announces New US Sales Executive
Date:4/1/2011

OCEANSIDE, N.Y., April 1, 2011 /PRNewswire/ -- Ellman International, Inc., a New York based manufacturer of radiofrequency (RF) devices for surgical and aesthetic procedures, today announced the appointment of Dennis S. Herman to the position of Senior Vice President, US Sales.

Herman brings over 20 years of sales leadership and aesthetic market experience with leading companies to Ellman.  "Dennis' proven success in leading sales teams to significant revenue growth coupled with his expertise in energy based surgical and aesthetic markets will be of great value as we further strengthen our position as a leader in both of these important sectors," said Chief Executive Officer Rick Epstein.

Most recently, Herman served as Senior VP of North American Sales for Candela Laser Corporation where his sales leadership resulted in growth of the business to the top position in the industry.  He has also held sales management positions of increasing responsibility at Palomar Medical Technology, Inc. including its subsidiary Spectrum Medical Technologies, Inc.

"I am pleased to be joining Ellman at such an exciting time and look forward to leading the US sales team to further success in the both the surgical and aesthetic markets," said Herman.

"Dennis is recognized for inspiring trust, loyalty and respect among his sales team, his customers and thought leaders in Dermatology.  His knowledge and expertise will be an excellent complement to our management team," added Epstein.

About Ellman International

Established in 1959, Ellman International (Oceanside, New York) maker of the Pelleve™ Wrinkle Reduction System, a revolutionary skin tightening system for non-ablative skin rejuvenation is a privately held developer, manufacturer and marketer of high frequency electrosurgical devices.  Ellman is a trusted leader in products for surgical procedures requiring cutting, coagulating, and tissue ablation in physician's offices and clinics. The company's advanced technologies offer unique versatility and precision to the surgical and aesthetic markets. In 2008, Baird Capital Partners and an investment group which includes Ellman's senior executives acquired Ellman.  

© 2011 Ellman International, Inc. All Rights Reserved.

ellman® International, Inc.

3333 Royal Avenue, Oceanside, N.Y. 11572-3625 U.S.A.

(800) 835-5355 • Fax: (516) 569-0054 • www.ellman.com

For more information, visit www.ellman.com and www.pelleve.com


'/>"/>
SOURCE Ellman International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Ellman International Announces Executive Team Hire
2. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
3. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
4. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
5. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
6. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
7. Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism
8. Preclinical Data on Lead MEK Inhibitor, RDEA119, to be Presented at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
9. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
10. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
11. Survival Data for Avicenas Amyotrophic Lateral Sclerosis Drug Candidate, AL-02, to be Presented at 18th International Symposium on ALS/MND
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , Südkorea, 23. Februar 2017 LG Innotek ... Sterilisationsaufgaben vorgestellt. Die Sterilisationsleistung beträgt das 1,5-fache des 45-mW-Moduls ... Strahlung im Bereich zwischen 200 und 280 nm und eignet ... Bakterien, indem es ihre DNA zerstört. Das Produkt von ... ...
(Date:2/23/2017)... , Feb. 23, 2017 ITL Limited, ( ASX: ... excellent results for the half year ended 31 December 2016 compared ... Growth Update" presentation can be viewed here . ... (Dec 2015: $1.04m; up 104%) Earnings per share ... Revenue of $17.5m (Dec 2015: $15.7m; up 11%) ...
(Date:2/23/2017)... -- Research and Markets has announced the addition of the ... their offering. ... research Menopause Drugs Price Analysis and Strategies - 2016, provides drug pricing ... the following questions: What are the key ... in the Global Menopause market? What are the unit ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has published a ... an astounding statement when he says that the entire Bible was written for the ... times so plainly that anyone should be able to see the time period. He ...
(Date:2/24/2017)... Emeryville, CA (PRWEB) , ... February 24, 2017 ... ... Esparza for qualifying into the Senior International Elite division on February 12th. ... All Around divisions at the elite qualifier competition held in Las Vegas, Nevada. ...
(Date:2/23/2017)... ... 23, 2017 , ... The Lymphoma Research Foundation (LRF) – ... serving the lymphoma community through a comprehensive series of education programs, outreach initiatives ... Miami Beach to host its Swirl: Miami Wine Tasting Event on March 28, ...
(Date:2/23/2017)... ... 23, 2017 , ... Rosica Communications, a national PR ... media management, corporate communications, SEO and cause marketing, is opening an office in ... Hampshire, Massachusetts and Canada, Rosica will focus on expanding its footprint. , ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... uncertainty in clinical trials, today announced that Premier Research, a leading clinical development ... , Clinical trials are becoming increasingly complex, due in part to an array ...
Breaking Medicine News(10 mins):